Design, synthesis, and biological evaluation of small, high-affinity siglec-7 ligands: toward novel inhibitors of cancer immune evasion

Natural killer cells are able to directly lyse tumor cells, thereby participating in the immune surveillance against cancer. Unfortunately, many cancer cells use immune evasion strategies to avoid their eradication by the immune system. A prominent escape strategy of malignant cells is to camouflage...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Prescher, Horst (VerfasserIn) , Gütgemann, Stephan Alexander (VerfasserIn) , Watzl, Carsten (VerfasserIn) , Brossmer, Reinhard (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: January 19, 2017
In: Journal of medicinal chemistry
Year: 2017, Jahrgang: 60, Heft: 3, Pages: 941-956
ISSN:1520-4804
DOI:10.1021/acs.jmedchem.6b01111
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1021/acs.jmedchem.6b01111
Verlag, Volltext: https://doi.org/10.1021/acs.jmedchem.6b01111
Volltext
Verfasserangaben:Horst Prescher, Martin Frank, Stephan Gütgemann, Elena Kuhfeldt, Astrid Schweizer, Lars Nitschke, Carsten Watzl, and Reinhard Brossmer

MARC

LEADER 00000caa a2200000 c 4500
001 1581220782
003 DE-627
005 20220815015206.0
007 cr uuu---uuuuu
008 180924s2017 xx |||||o 00| ||eng c
024 7 |a 10.1021/acs.jmedchem.6b01111  |2 doi 
035 |a (DE-627)1581220782 
035 |a (DE-576)511220782 
035 |a (DE-599)BSZ511220782 
035 |a (OCoLC)1341019174 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 32  |2 sdnb 
100 1 |a Prescher, Horst  |e VerfasserIn  |0 (DE-588)1167703855  |0 (DE-627)1031226583  |0 (DE-576)511220758  |4 aut 
245 1 0 |a Design, synthesis, and biological evaluation of small, high-affinity siglec-7 ligands  |b toward novel inhibitors of cancer immune evasion  |c Horst Prescher, Martin Frank, Stephan Gütgemann, Elena Kuhfeldt, Astrid Schweizer, Lars Nitschke, Carsten Watzl, and Reinhard Brossmer 
264 1 |c January 19, 2017 
300 |a 16 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 24.09.2018 
520 |a Natural killer cells are able to directly lyse tumor cells, thereby participating in the immune surveillance against cancer. Unfortunately, many cancer cells use immune evasion strategies to avoid their eradication by the immune system. A prominent escape strategy of malignant cells is to camouflage themselves with Siglec-7 ligands, thereby recruiting the inhibitory receptor Siglec-7 expressed on the NK cell surface which subsequently inhibits NK-cell-mediated lysis. Here we describe the synthesis and evaluation of the first, high-affinity low molecular weight Siglec-7 ligands to interfere with cancer cell immune evasion. The compounds are Sialic acid derivatives and bind with low micromolar Kd values to Siglec-7. They display up to a 5000-fold enhanced affinity over the unmodified sialic acid scaffold αMe Neu5Ac, the smallest known natural Siglec-7 ligand. Our results provide a novel immuno-oncology strategy employing natural immunity in the fight against cancers, in particular blocking Siglec-7 with low molecular weight compounds. 
700 1 |a Gütgemann, Stephan Alexander  |e VerfasserIn  |0 (DE-588)1024146952  |0 (DE-627)71977604X  |0 (DE-576)368012743  |4 aut 
700 1 |a Watzl, Carsten  |e VerfasserIn  |0 (DE-588)1076837557  |0 (DE-627)835380742  |0 (DE-576)175362297  |4 aut 
700 1 |a Brossmer, Reinhard  |d 1925-2020  |e VerfasserIn  |0 (DE-588)1115343556  |0 (DE-627)869722298  |0 (DE-576)324407076  |4 aut 
773 0 8 |i Enthalten in  |t Journal of medicinal chemistry  |d Washington, DC : ACS, 1959  |g 60(2017), 3, Seite 941-956  |h Online-Ressource  |w (DE-627)302468846  |w (DE-600)1491411-6  |w (DE-576)090855132  |x 1520-4804  |7 nnas  |a Design, synthesis, and biological evaluation of small, high-affinity siglec-7 ligands toward novel inhibitors of cancer immune evasion 
773 1 8 |g volume:60  |g year:2017  |g number:3  |g pages:941-956  |g extent:16  |a Design, synthesis, and biological evaluation of small, high-affinity siglec-7 ligands toward novel inhibitors of cancer immune evasion 
856 4 0 |u http://dx.doi.org/10.1021/acs.jmedchem.6b01111  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://doi.org/10.1021/acs.jmedchem.6b01111  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180924 
993 |a Article 
994 |a 2017 
998 |g 1115343556  |a Brossmer, Reinhard  |m 1115343556:Brossmer, Reinhard  |d 700000  |d 711000  |e 700000PB1115343556  |e 711000PB1115343556  |k 0/700000/  |k 1/700000/711000/  |p 8  |y j 
998 |g 1076837557  |a Watzl, Carsten  |m 1076837557:Watzl, Carsten  |d 910000  |d 911600  |e 910000PW1076837557  |e 911600PW1076837557  |k 0/910000/  |k 1/910000/911600/  |p 7 
998 |g 1024146952  |a Gütgemann, Stephan Alexander  |m 1024146952:Gütgemann, Stephan Alexander  |p 3 
999 |a KXP-PPN1581220782  |e 3026232033 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Horst Prescher, Martin Frank, Stephan Gütgemann, Elena Kuhfeldt, Astrid Schweizer, Lars Nitschke, Carsten Watzl, and Reinhard Brossmer"]},"id":{"doi":["10.1021/acs.jmedchem.6b01111"],"eki":["1581220782"]},"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"January 19, 2017"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Washington, DC ; Easton, Pa.","dateIssuedDisp":"1959-","publisher":"ACS ; ACS","dateIssuedKey":"1959"}],"id":{"zdb":["1491411-6"],"eki":["302468846"],"issn":["1520-4804"]},"name":{"displayForm":["American Chemical Society"]},"pubHistory":["1.1959 -"],"part":{"pages":"941-956","issue":"3","year":"2017","extent":"16","text":"60(2017), 3, Seite 941-956","volume":"60"},"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 02.10.2020"],"disp":"Design, synthesis, and biological evaluation of small, high-affinity siglec-7 ligands toward novel inhibitors of cancer immune evasionJournal of medicinal chemistry","recId":"302468846","language":["eng"],"title":[{"title_sort":"Journal of medicinal chemistry","title":"Journal of medicinal chemistry"}]}],"physDesc":[{"extent":"16 S."}],"person":[{"given":"Horst","family":"Prescher","role":"aut","display":"Prescher, Horst","roleDisplay":"VerfasserIn"},{"family":"Gütgemann","given":"Stephan Alexander","roleDisplay":"VerfasserIn","display":"Gütgemann, Stephan Alexander","role":"aut"},{"given":"Carsten","family":"Watzl","role":"aut","roleDisplay":"VerfasserIn","display":"Watzl, Carsten"},{"given":"Reinhard","family":"Brossmer","role":"aut","roleDisplay":"VerfasserIn","display":"Brossmer, Reinhard"}],"title":[{"subtitle":"toward novel inhibitors of cancer immune evasion","title":"Design, synthesis, and biological evaluation of small, high-affinity siglec-7 ligands","title_sort":"Design, synthesis, and biological evaluation of small, high-affinity siglec-7 ligands"}],"language":["eng"],"recId":"1581220782","note":["Gesehen am 24.09.2018"],"type":{"bibl":"article-journal","media":"Online-Ressource"}} 
SRT |a PRESCHERHODESIGNSYNT1920